← Back to Clinical Trials
Recruiting NCT05546346

NCT05546346 Clinical Application of Wearable Magnet Tracking System for Capsule Endoscopes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05546346
Status Recruiting
Phase
Sponsor Qilu Hospital of Shandong University
Condition Capsule Endoscopes
Study Type INTERVENTIONAL
Enrollment 10 participants
Start Date 2023-03-30
Primary Completion 2025-10-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 75 Years
Study Type INTERVENTIONAL
Interventions
wearable magnet tracking system

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 10 participants in total. It began in 2023-03-30 with a primary completion date of 2025-10-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The investigators developed a wearable magnet tracking system, which provided a non-invasive and high accuracy method for capsule endoscopes localization. Data fusion from multiple sensors expanded positioning range and proposed localization algorithm overcame shortcomings of existing systems. This clinical trial was conducted to verify effectiveness and stability of the tracking system.

Eligibility Criteria

Inclusion Criteria: * aged between 18 and 75 * agree to give written informed consent Exclusion Criteria: * dysphagia or symptoms of gastric outlet obstruction, suspected or known intestinal stenosis, overt gastrointestinal bleeding, history of upper gastrointestinal surgery or abdominal surgery altering gastrointestinal anatomy, or postabdominal radiation * congestive heart failure, renal insufficiency, under therapeutic anticoagulation, in poor general condition (American Society of Anesthesiologists class III/IV), claustrophobia, metallic parts, a pacemaker or other implanted electromedical devices, or artificial heart valves * pregnancy or suspected pregnancy * exclusion criteria for standard magnetic resonance imaging examination such as the presence of surgical metallic devices, even though its low magnetic field technically would not interferewith such devices * currently participating in another clinical study

Contact & Investigator

Central Contact

Jingran Su, PhD

✉ taylor1943@163.com

📞 18769787193

Frequently Asked Questions

Who can join the NCT05546346 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 75 Years, studying Capsule Endoscopes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05546346 currently recruiting?

Yes, NCT05546346 is actively recruiting participants. Contact the research team at taylor1943@163.com for enrollment information.

Where is the NCT05546346 trial being conducted?

This trial is being conducted at Jinan, China.

Who is sponsoring the NCT05546346 clinical trial?

NCT05546346 is sponsored by Qilu Hospital of Shandong University. The trial plans to enroll 10 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology